Introduction
In recent years, bottom-of-the-sulcus dysplasia (BOSD) has been identified as a form of focal cortical dysplasia associated with drug-resistant epilepsy [1] . With advances in neuroimaging, BOSD is now more readily detected. Seizure-free rates after surgery approach 90%, thus making patients with drug-resistant epilepsy from BOSD excellent candidates for epilepsy surgery.
However, resection of BOSD near eloquent cortex can result in motor dysfunction in patients undergoing craniotomy-based neurosurgery [2] . Other treatment alternatives are needed for this population of patients.
Report of a case
A 28-year-old right-handed man presented with drug-resistant focal epilepsy beginning at age 4.
His childhood seizure semiology consisted of altered responsiveness, lip smacking, and rare secondary generalization. As an adult, his seizure semiology evolved and was characterized by a several-hour prodrome of dizziness and malaise, followed by rightward head rotation lasting approximately 20 s, with occasional preserved awareness. He was hospitalized twice for status epilepticus. Medications trialed include carbamazepine, divalproic acid, lamotrigine (with 3-year seizure-free period), levetiracetam, and oxcarbazepine. He has 1-2 seizures monthly, often occurring in clusters and forcing him to stay off work 1-3 days per month. (Fig. 1) .
Intracranial EEG monitoring was performed with all contacts implanted over left frontal, temporal and parietal lobes. Electrodes consisted of two 10-contact stereotactic depth electrodes implanted immediately anterior and posterior to the suspected cortical dysplasia, one 8 Â 8 grid overlying left frontal and parietal lobe, one 4 Â 4 grid immediately anterior to the 8 Â 8 grid and covering anterior-lateral left frontal lobe and one 1 Â 6 strip longitudinally covering the left superior temporal gyrus. Chronic intracranial EEG recordings over 8 days showed near continuous interictal spike discharges from the deep contacts of the anterior and posterior stereotactic depth electrodes. Spontaneous and provoked seizures during electrocorticography began in the posterior depth electrode contact at the depth of the sulcus (Fig. 2) . Electrical stimulation through the contact points of the stereotactic depth electrodes did not produce any motor response. Bipolar electrical stimulation with 2 mA of current delivered to tissue near the distal contacts of the posterior stereotactic depth electrode produced the patient's stereotyped habitual seizure on two separate occasions. The seizure began in the most distal contact of the posterior stereotactic depth electrode, which was positioned at the posterior border of the MRI lesion. Electrical stimulation of the cortical gyrus immediately posterior to the sulcal lesion elicited contralateral hand movement. No electrographic seizures were induced by electrical stimulation of any surface grid electrode.
At our surgical epilepsy case conference, surgical lesionectomy was ruled out because of concerns for postoperative dominant hand dysfunction. Patient underwent stereotactic laser thermoablation of the sulcal lesion, without any postoperative deficits. His outcome is Engel Class 1a at 1-year follow-up. Seizure freedom has allowed our patient to pursue his lifelong dream of travel, and he is currently teaching English to middle-school children in Japan. No tissue specimens are obtainable during thermoablation. In our case, the diagnosis of BOSD is strongly supported by the classic clinical history, MRI findings, and intracranial stereo-EEG data [2] .
Discussion
Stereotactic laser thermoablation is a relatively new and minimally invasive surgical technique using heat to thermocoagulate brain lesions. Since 2012, small case series of patients who underwent laser thermoablation to treat drug-resistant epilepsy from multiple etiologies (hypothalamic hamartomas, periventricular nodular heterotopia, medial temporal lobe epilepsy, focal cortical dysplasia) have been reported, with excellent results [3, 4] . The procedure is well-tolerated, and most patients are discharged the day after surgery. However, thermoablation of epileptogenic tissue is a relatively new technique, and more data are needed to determine if long-term seizure-free outcome following this procedure is comparable to open resection. Thermoablation of brain tissue is not without potential complications, and earlier studies have reported a small risk of bleeding complications [3] . Another limitation of laser thermoablation is the absence of tissue specimens for pathologic diagnosis.
Drug-resistant epilepsy is a disabling disease and seizures from BOSD can be cured with lesionectomy. However, when dysplastic tissue is located near eloquent cortex, traditional neurosurgical resection has been associated with postoperative deficits, including persistent contralateral paresis. Without surgical treatment, our patient would face lifelong seizures and a diminished quality of life. Our case provides proof of concept that stereotactic laser thermoablation can safely and effectively treat patients with drug-resistant epilepsy from BOSD near eloquent cortex. Further studies will elucidate whether this minimally invasive technique can one day supplant craniotomybased surgery in the treatment of certain cases of medically refractory epilepsy.
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